meranzin: structure in first source
ID Source | ID |
---|---|
PubMed CID | 1803558 |
SCHEMBL ID | 14315527 |
MeSH ID | M0495648 |
Synonym |
---|
meranzin |
8-[[(2s)-3,3-dimethyloxiran-2-yl]methyl]-7-methoxychromen-2-one |
SCHEMBL14315527 |
2h-1-benzopyran-2-one, 8-[[(2s)-3,3-dimethyloxiranyl]methyl]-7-methoxy- |
2h-1-benzopyran-2-one, 8-[[(2s)-3,3-dimethyl-2-oxiranyl]methyl]-7-methoxy- |
2h-1-benzopyran-2-one, 8-[(3,3-dimethyloxiranyl)methyl]-7-methoxy-, (s)- |
LSZONYLDFHGRDP-LBPRGKRZSA-N |
coumarin, 8-(2,3-epoxy-3-methylbutyl)-7-methoxy-, (-)- |
(-)-meranzin |
merancin |
AC-34114 |
HY-N3298 |
CS-0023841 |
MS-23666 |
mfcd02683834 |
AKOS040760112 |
Excerpt | Reference | Relevance |
---|---|---|
"The present study aimed to develop a strategy involving quantitative analysis of multicomponents by single marker in combination with high-performance liquid chromatography fingerprint qualitative analysis for performing the quality control of Aurantii Fructus." | ( Quantitative analysis of multicomponents by single marker combined with HPLC fingerprint qualitative analyses for comprehensive evaluation of Aurantii Fructus. Cai, X; Huang, D; Lei, Y; Lin, M; Luo, K; Sun, Z; Tan, S; Wang, Y; Xia, X; Yan, J; Zhang, Y, 2020) | 0.56 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |